Topical Herbal Plasters for Cancer Pain

This trial aims to determine if Tibetree pain-relieving plasters, applied to the skin, can help manage pain for cancer patients already using opioids. Researchers seek to assess whether these herbal plasters are practical and effective for targeting specific pain areas. Participants should have cancer-related pain that a single plaster can cover and currently use short-term oral opioids like oxycodone or morphine. As a Phase 1 trial, the research focuses on understanding how the treatment works in people, offering participants the opportunity to be among the first to receive this new treatment.

The trial does not specify that you must stop taking your current medications, but you cannot start or change pain management strategies or cancer treatments shortly before or after joining the trial. You also need to stop using any current localized topical pain treatments for the most severe pain site.

Research has shown that Tibetree Pain-Relieving Plasters are being tested for safety and effectiveness in managing pain, particularly in cancer survivors. One study suggested that these plasters, when combined with regular opioid painkillers, might offer a safe and manageable option for pain relief. Although these studies provide some evidence, they represent early findings, and further research is necessary to confirm their safety. Currently, available data suggests that the plasters could be a practical method for managing localized pain.¹²³⁴⁵

Unlike the standard of care for cancer pain, which often includes medications like opioids and NSAIDs, Tibetree Pain-Relieving Plasters offer a unique approach by using a topical herbal formulation. Researchers are excited about these plasters because they provide a non-invasive, localized treatment option that minimizes systemic side effects commonly associated with oral medications. Additionally, the herbal ingredients might offer a novel mechanism of action by targeting pain pathways directly at the skin level, potentially providing faster and more targeted relief.

Studies have shown that Tibetree Pain-Relieving Plasters can reduce pain by lowering inflammation. Research indicates these plasters have been effective for individuals with long-term pain, including cancer survivors. One study found that users experienced a noticeable decrease in pain and improved ability to perform daily activities. In this trial, participants in the topical herbal plaster arm will use the Tibetree Pain-Relieving Plasters on Days 1-7 of the treatment period. Meanwhile, participants in the waitlist control group will use the plasters on Days 8-14 after a 7-day waiting period. Although more research is needed, early evidence suggests these plasters could complement regular pain management, especially for those already taking opioids.¹²³⁴⁵